Moringa

<h3> Absolute Contraindications of Moringa </h3> <h4> Pregnancy / early pregnancy (If you are pregnant or trying to conceive)</h4> <ul> <li>🤰</li> <li>Recommendation: Avoid medicinal or high-dose Moringa leaf/seed preparations during pregnancy; if pregnant and have used Moringa, discuss with your healthcare provider promptly.</li> <li>Reasoning: Animal studies report that certain Moringa preparations (leaf powders/extracts and particularly some root/bark preparations) produced significant abortifacient or pre-/post-implantation effects at experimental doses, indicating risk when taken as a concentrated medicinal product.</li> <li>Scientific_Study_Title: Abortifacient activity of a medicinal plant "moringa oleifera" in rats.</li> <li>Scientific_Study_Authors: N Sethi, D Nath, S C Shukla, R Dyal.</li> <li>Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/22557610/</li> <li>Scientific_Study_Excerpt: <p>The 1988 experimental report tested dried leaf powder administered orally to pregnant rats (175 mg/kg daily, days 5-10 post-mating) and observed a measurable abortifacient effect under those conditions. The authors described loss of pregnancy in treated animals compared with controls and concluded the extract displayed antifertility activity in that animal model. While this is an animal study (not a human clinical trial), the findings are consistent with traditional caution about using concentrated parts of the plant in pregnancy and justify avoiding medicinal/high-dose use by pregnant people.</p> </li> </ul> <h4>Severe liver disease / active hepatic injury</h4> <ul> <li>🛑</li> <li>Recommendation: Do not take high-dose Moringa extracts if you have active severe liver disease; if you are considering any Moringa supplement, consult your hepatologist first and prefer small dietary amounts only under supervision.</li> <li>Reasoning: Animal subchronic studies with concentrated methanolic or powdered preparations showed dose-related increases in liver enzymes and histologic liver changes at higher experimental doses, indicating potential for liver stress with prolonged high-dose exposure.</li> <li>Scientific_Study_Title: Toxicological evaluations of methanolic extract of Moringa oleifera leaves in liver and kidney of male Wistar rats.</li> <li>Scientific_Study_Authors: Ademola A Oyagbemi, Temitayo O Omobowale, Ibraheem O Azeez, John O Abiola, Rahamon A M Adedokun, Helen O Nottidge.</li> <li>Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/23509212/</li> <li>Scientific_Study_Excerpt: <p>In this repeated-dose rat study animals received methanolic leaf extract at graded doses for 8 weeks. Rats given 200 and 400 mg/kg showed statistically significant increases in serum liver enzymes (ALT, AST) and histologic evidence consistent with hepatic injury compared to controls. The authors concluded that chronic administration of high-dose extract may predispose to hepatic damage in this model. These findings suggest caution with long-term or high-dose medicinal use in humans with pre-existing liver disease, although typical culinary use of leaves is much lower.</p> </li> </ul> <h4>Severe kidney disease (advanced renal impairment)</h4> <ul> <li>⚠️</li> <li>Recommendation: Avoid medicinal-strength Moringa supplements if you have advanced kidney disease; discuss any use with your nephrologist. Small culinary amounts are less likely to be harmful but professional advice is advised.</li> <li>Reasoning: Some animal toxicity studies of concentrated powders/extracts reported elevations in BUN/creatinine and histologic kidney changes at higher doses, indicating kidney stress when taken long term at concentrated doses.</li> <li>Scientific_Study_Title: Evaluation of acute toxicity, 28-day repeated dose toxicity, and genotoxicity of Moringa oleifera leaves infusion and powder.</li> <li>Scientific_Study_Authors: (See article: authors listed on PubMed entry: authors vary by paper - use the linked article for full list.)</li> <li>Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/35760258/</li> <li>Scientific_Study_Excerpt: <p>This 28-day repeated dose study compared infusion and powder forms in mice and showed that while the infusion was well tolerated, administration of leaf powder at 500 and 1000 mg/kg produced biochemical and histopathologic evidence of liver and kidney damage, including altered renal markers. The data indicate that concentrated powders (not typical culinary portions) can stress kidneys in rodents; therefore individuals with impaired renal function should avoid medicinal-strength preparations and consult their clinician before use.</p> </li> </ul> <h3> Relative Contraindications of Moringa </h3> <h4>Use with antidiabetic medications (insulin, sulfonylureas, metformin)</h4> <ul> <li>🩺</li> <li>Recommendation: If you take glucose-lowering drugs, consult your prescribing clinician before starting Moringa; your medication dose may need closer monitoring and potential adjustment to avoid hypoglycaemia.</li> <li>Reasoning: Human and animal studies show Moringa reduces post-meal glucose and can improve HbA1c; when combined with pharmaceutical hypoglycemics there is theoretical and experimental risk of additive blood glucose lowering.</li> <li>Scientific_Study_Title: Effect of Moringa oleifera Leaf Powder on Postprandial Blood Glucose Response: In Vivo Study on Saharawi People Living in Refugee Camps.</li> <li>Scientific_Study_Authors: Alessandro Leone, Simona Bertoli, Sara Di Lello, Angela Bassoli, Stefano Ravasenghi, Gigliola Borgonovo, Fabio Forlani, Alberto Battezzati.</li> <li>Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/30322091/</li> <li>Scientific_Study_Excerpt: <p>In this human study, adding 20 g of Moringa leaf powder to a traditional meal reduced the postprandial glucose rise in diabetic participants versus the control meal, with lower increments and an earlier peak. The trial demonstrated a measurable hypoglycemic adjunct effect in people with diabetes. Although the study used a food dose, the findings illustrate how Moringa can alter glucose excursions and therefore may increase the hypoglycemic effect when combined with insulin or sulfonylureas, warranting monitoring and possible dose adjustments.</p> </li> </ul> <h4>Use with antihypertensive medications (ACE inhibitors, ARBs, beta-blockers)</h4> <ul> <li>💊</li> <li>Recommendation: If you are on blood-pressure medications, check with your doctor before adding medicinal doses of Moringa; monitor blood pressure closely and adjust therapy if needed.</li> <li>Reasoning: Moringa peptides and constituents have demonstrated ACE and renin inhibitory activity and lowered blood pressure in experimental models and small human studies; combining with prescribed antihypertensives could produce additive hypotension.</li> <li>Scientific_Study_Title: Antihypertensive activity of the ACE-renin inhibitory peptide derived from Moringa oleifera protein.</li> <li>Scientific_Study_Authors: Keer Ma, Yujiao Wang, Mingjie Wang, Zhigao Wang, Xuefeng Wang, Xingrong Ju, Rong He.</li> <li>Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/34382048/</li> <li>Scientific_Study_Excerpt: <p>Researchers extracted protein hydrolysates from Moringa leaves, isolated <1 kDa peptide fractions, and observed strong ACE and renin inhibition in vitro; oral administration of the active fraction lowered systolic and diastolic blood pressure in hypertensive rats by roughly 17-19 mmHg. The molecular data and animal effects support the concept that Moringa contains potent, bioavailable antihypertensive peptides, so simultaneous use with antihypertensive drugs could augment blood-pressure lowering.</p> </li> </ul> <h4>Use with anticoagulant/antiplatelet drugs (warfarin, DOACs, aspirin)</h4> <ul> <li>🩸</li> <li>Recommendation: If you take blood thinners, avoid medicinal-strength Moringa preparations or discuss with your clinician; frequent INR/bleeding-risk monitoring is advised if co-use is considered.</li> <li>Reasoning: Moringa contains proteins (and other constituents) that inhibit thrombin activity in vitro; this indicates potential to increase anticoagulant effect and bleeding risk when used with therapeutic anticoagulants.</li> <li>Scientific_Study_Title: A Non-competitive Serpin-Like Thrombin Inhibitor Isolated from Moringa oleifera Exhibit a High Affinity for Thrombin.</li> <li>Scientific_Study_Authors: Sawetaji, Kamal Krishan Aggarwal.</li> <li>Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/37149510/</li> <li>Scientific_Study_Excerpt: <p>Investigators isolated a ~50 kDa protein from Moringa that acted as a non-competitive inhibitor of human thrombin in vitro, with substantial thrombin inhibition at low microgram amounts and an IC50 in the low µg range. The work demonstrates a direct biochemical anticoagulant potential of a Moringa-derived protein, providing a plausible mechanistic basis for additive bleeding risk if Moringa preparations are used together with clinical anticoagulants or antiplatelet agents.</p> </li> </ul>